100,000 Amazon Mattresses Recalled Over Fire Hazard
By I. Edwards HealthDay Reporter

MONDAY, June 23, 2025 — If you bought a Crayan mattress on Amazon in the last two years, you may need to stop using it right away.
About 100,000 mattresses are being recalled because they don’t meet federal flammability standards, the U.S. Consumer Product Safety Commission (CPSC) said in a notice posted June 18.
The mattresses can pose a fire hazard, although no injuries or incidents have been reported so far, Parade said in a report.
The recall involves Crayan brand 10- and 12-inch mattresses in twin, full, queen and king sizes.
The mattresses are single-sided with a white quilted top and gray sides. The name “Crayan” appears on the gray side panel, and the label includes mattress size, fiber content and “WG/P Foundation.”
The recalled mattresses were made in Japan and sold only on Amazon.com between July 2022 and June 2024. Prices ranged from $100 to $220, Parade said.
If you own one of these mattresses, stop using it immediately.
To get a refund, contact Crayan at [email protected].
You’ll be asked to mark the mattress with the word “Recalled” in large letters across the white top panel. Then, send a photo of the marked mattress to the email address above.
Once approved, Crayan will issue a full refund.
The company says it has already contacted customers who purchased the mattresses. But if you think you may have missed the notice, it's worth checking your order history on Amazon or contacting Crayan directly.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-24 06:00
Read more

- Weed Use Linked To Heart-Related Deaths
- Doctors' Preferences for Their Own End-of-Life Care? No Life-Sustaining Practices
- Electronic Nudge Letters Do Not Improve Guideline-Directed Medical Therapy in CKD
- 'Forever Chemicals' Linked To Elevated Childhood Blood Pressure
- How Wildfires Might Increase Risk Of Flu, COVID-19
- 2023 Unintentional Fall Death Rate Was 69.9/100,000 in Those Aged 65 and Older
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions